Sign up now to receive our regular news briefs.

Israeli Start-Up Alcobra Develops New Treatment for Attention Deficit Disorder

December 2, 2013 3:26 pm 2 comments
Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israel's Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Israeli pharmaceutical start-up Alcobra Pharmaceuticals is listed on the NASDAQ electronic stock exchange under the ticker ADHD, the disease it treats with a non-stimulant compound that is expected to come to the market in 2015.

In an interview with Israeli business daily Globes, CEO Dr. Yaron Daniely explained how the company was originally created in 2008 to develop the molecule metadoxine to help inhibit the effects of alcohol on the brain.

“The goal was to create a pill that would quickly reduce blood alcohol levels, so that people would be able to drive safely,” explains Daniely. “It turned out the drug had no significant impact on removing alcohol from the blood, but it had a very significant impact on cognitive ability. In driving, memory, and attention tests that were conducted, it was as though those people were not drunk, despite the fact that, in terms of the amount of alcohol in their blood, it was not clear that they would be able to stand on their own two feet. So the idea to treat Attention Deficit Disorder came about.”

A pilot the company conducted in 2010 among 40 adults with ADHD showed “an immediate and significant improvement in attention tests. As a result of this, the company reinvented itself,” Daniely said, which is when he was named by researchers Dr. Dalia Megiddo and Udi Gilboa to be its new CEO.

Bilingual with a Ph.D. from the Sackler Institute of Graduate Biomedical Sciences at the New York University School of Medicine, an NIH Visiting Fellow in Cell Biology, a Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science, in Rehovot, and an MBA from the Technion – Israel Institute of Technology, Daniely also was VP Business Development at Gamida Cell Ltd., managing its joint venture with Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA) to develop a cancer drug.

The idea was to approach TEVA to fund the start-up, which it did with $5 million to fund its first tests. But with TEVA later in a management crisis, and its options to increase its position in Alcobra expired, the team sought an IPO on the NASDAQ, which has since net it some $60 million in proceeds and a market capitalization of $220 million, more than enough to fund its final tests and market launch.

Daniely said the chemical compound metadoxine has been approved for 40 years for the treatment of liver disease in third-world countries, including India, China, Russia, and Thailand. The company has registered a patent for the use of metadoxine for neurological conditions, through a timed-release of the substance, so its effect on the patient lasts a few hours.

Globes said that Alcobra has no labs, its raw materials are manufactured by a third party in Germany, and the pills themselves are manufactured in the US. The company believes that the drug combines the benefits of the two existing classes of ADHD drugs – the stimulants, such as Ritalin and Concerta, and the non-stimulant drugs, such as Strattera – and claims that it does not have their drawbacks.

According to the company, the results of the clinical trials showed that the drug is not addictive, worked faster and was twice as effective as the existing non-stimulant drugs, and had a similar anti-ADHD effect to that of the stimulants. It primarily affects cognitive ability, less so hyperactivity.

Daniely advised other Israeli start-ups to follow four lessons from Alcobra’s successful IPO. “The first element was quality, and a refusal to compromise,” he said. “Alcobra, from day one, tried to be different from other companies. We have an almost pedantic stubbornness not to do things too small or too short, but rather to do the things the way we would if we were a company in Silicon Valley. Therefore, our Phase II trial didn’t include 20 people over two weeks, instead, it included 120 people, with a placebo control, over the course of six weeks, using the exact same measures that all the ADHD drugs in the world are measured by. Many companies understand too late that they are conducting poorer trials without the appropriate controls.”

The second element was the company’s target market. “There’s nothing like ADHD,” he says. “First of all, people understand the market; there are drugs, it is known how much each company is selling and why, there are patients, there is a market that turns over $4 billion each year in the US. Also, people think they understand what ADHD is. It affects almost everyone, their kid, or their nephew.”

A third element is the pace of development: “With ADHD, unlike rare cancers, participants for clinical trials are incredibly easy to find. So our time to market and our ability to build our development process are such that almost every month we have good news for shareholders. The phase III trial will include 300 patients, in 20 medical centers, over the course of six months.”

The fourth element that helped secure funding was his native-English speaking ability, personal CV and track record and a decision to invite well-known professionals from the ADHD research community to be on their team, in this case, Prof. Lenard Adler, a researcher from NYU and an expert in ADHD drug development, who serves as head of the clinical committee that advises the company. “When someone like him sits next to you and says: ‘I conducted the trial and I stand behind the results,’ they can’t blow you off. Israeli entrepreneurs need to understand this and bring these people to their companies, so they can bridge the gap,” Daniely said.

While the company tried to get funding in Israel, where ADHD is less frequently diagnosed, its success in raising money on the NASDAQ has led many other young pharma companies to its doors, seeking advice. Its success has also led to new projects.

“Many things happened at the company, and our ability to implement plans grew. We had a tremendous opportunity to treat fragile X syndrome, which is associated with autism. It is a very common condition, which is very difficult for many who suffer from it, and there is no treatment. In a trial we conducted on animals with a kind of fragile X, we came up with outstanding results. It completely normalized learning, memory, social behavior, and communication. In parallel, the market in the US was still on fire, and said, ‘go, secure the investment, and bring in more cash,'” Daniely said.

The funds Alcobra raised guarantee that the company will have full funding until it is approved as a drug for adult ADHD, which, according to Daniely, is expected to reach market in late 2015, and for children soon afterwards. The money will also fund the fragile X trial.

2 Comments

  • In this period of financial crisis, you usually do not have to spend huge amount of money just to find out girls
    get their clothes off in front individuals. You have to discover once the nude models from the sex chat website can be extremely beautiful and
    deliciously attractive. Military husbands stationed in the Middle
    East have been in a position to witness the birth of an youngster through webcams.

  • Davida Rosenberg

    Please update me when this will be available in the U.S.
    A family member age 36 male.. has suffered his whole young life with this condition.

Leave a Reply

Please note: comments may be published in the Algemeiner print edition. Comments written in all caps will be deleted.


Current day month ye@r *

More...

  • Blogs Sports Two Decades Before Cleveland’s First NBA Title, LeBron James Walked Onto a JCC Court

    Two Decades Before Cleveland’s First NBA Title, LeBron James Walked Onto a JCC Court

    JNS.org – The seed for the city of Cleveland’s first professional championship in a major sport in 52 years may have been planted at the Shaw Jewish Community Center on White Pond Drive in Akron, Ohio, nearly 20 years ago. That’s when a tall, lanky kid from Akron named LeBron James walked onto the hardwood court and changed the game of basketball forever. Coach Keith Dambrot, now the head basketball coach at the University of Akron, conducted those sessions that attracted […]

    Read more →
  • Arts and Culture Blogs North American Studios Look to Israel for Next Animation Hit

    North American Studios Look to Israel for Next Animation Hit

    JNS.org – In 2008, Yoram Honig was a producer and director living in Jerusalem, fresh off his first international hit, when the Jerusalem Development Authority (JDA) came to him with a challenge: build a film industry from scratch in Israel’s capital. “When we started here, was nothing in Jerusalem,” he said during an interview in his office in the Talbiya neighborhood. Now, the Jerusalem Film and Television Fund, which Honig heads as an arm of the JDA, pumps 9 million shekels […]

    Read more →
  • Blogs Sports Olympic Gold Medalist Gabby Douglas to Wear Leotard With Hebrew Letters in National Competition

    Olympic Gold Medalist Gabby Douglas to Wear Leotard With Hebrew Letters in National Competition

    Olympic gold medalist Gabby Douglas will wear a leotard bearing Hebrew lettering when she competes at the P&G Gymnastics Championships over the weekend. Douglas’ Swarovski-outlined outfit will feature the Hebrew word “Elohim,” meaning God, on its left sleeve. The Hebrew detailing honors the athlete’s “rich heritage of faith,” according to apparel manufacturer GK Elite, which produced the leotard and released a preview of it on Wednesday. The company said Douglas’ sister, Joyelle “Joy” Douglas, created the Hebrew design. The outcome of the P&G Championships will help […]

    Read more →
  • Europe Sports British World Heavyweight Champion Should Be Banned From Boxing for Sounding Like Hitler, Says Ukrainian Competitor

    British World Heavyweight Champion Should Be Banned From Boxing for Sounding Like Hitler, Says Ukrainian Competitor

    Britain’s world heavyweight champion, Taylor Fury, should be banned from boxing for making Nazi-like comments, a former world champion from the Ukraine said on Thursday, ahead of their upcoming match. “I was in shock at his statements about women, the gay community, and when he got to the Jewish people, he sounded like Hitler,” Wladimir Klitschko told British media, according to Reuters. “We cannot have a champion like that. Either he needs to be shut up or shut down in the ring, or […]

    Read more →
  • Arts and Culture Rabbi Shows Cooking Skills and Humor on Chopped

    Rabbi Shows Cooking Skills and Humor on Chopped

    Rabbi Hanoch Hecht just made television history; but, unfortunately, he couldn’t have his rugelach and eat it too. Hecht became the first rabbi to compete on the hit show “Chopped,” where contestants are forced to use four random ingredients in their recipes, and have 20-30 minutes to create an appetizer, a main course and a dessert. A contestant is eliminated after each round. Hecht, 32, said that while the dishes and utensils were new, the kitchen was not kosher, so he couldn’t taste […]

    Read more →
  • Blogs Music Orthodox Entertainer Stars in Pepsi Max Commercial as New Face of Company’s Israel Campaign (VIDEO)

    Orthodox Entertainer Stars in Pepsi Max Commercial as New Face of Company’s Israel Campaign (VIDEO)

    Orthodox singer and entertainer Lipa Schmeltzer is starring in a new Pepsi Max commercial for the company’s campaign in Israel. The commercial begins with a bunch of Jewish men eating at a restaurant, when Schmeltzer walks in and tries to decide what to order. An employee at the obviously Israeli eatery offers him a variety of foods, but the entertainer in the end decides on a bottle of Pepsi. Everyone in the restaurant then joins him, drinking Pepsi Max and dancing to […]

    Read more →
  • Arts and Culture Book Reviews Jewish Author’s ‘Messy’ Draft Transforms Into Rock Star Novel on Amazon

    Jewish Author’s ‘Messy’ Draft Transforms Into Rock Star Novel on Amazon

    JNS.org – “Writing is a messy process,” says author Elizabeth Poliner. “People who don’t write fiction would be surprised to see what early drafts could look like.” But readers wouldn’t know “what a mess it was for the longest time,” as the Jewish author puts it, when reading Poliner’s critically acclaimed latest book, As Close to Us as Breathing. The volume garnered Amazon’s “Best Book” designation in March 2016 as well as rave reviews from the New York Times,W Magazine, NPR, […]

    Read more →
  • Arts and Culture Blogs Sundance Tour Features Short Film About Elderly Jewish Woman’s Decision to Eat Bacon for First Time

    Sundance Tour Features Short Film About Elderly Jewish Woman’s Decision to Eat Bacon for First Time

    The Sundance Film Festival Short Film Tour, which started on Friday in New York City, features a mini-documentary about an elderly Jewish woman whose journey away from Orthodoxy leads her to taste forbidden food for the first time in her life. In Canadian director Sol Friedman’s Bacon & God’s Wrath, Razie Brownstone talks about ending her lifelong observance of keeping kosher as her 90th birthday approaches. The recently declared atheist said the discovery of the search engine Google spurred a lapse in her Jewish faith and made her decide to […]

    Read more →